AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sienna Biopharmaceuticals, Inc.

$0 +$0.00 (+9,900%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
3.09K
AVG Volume
985
Trailing/Forward PE
-0/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Net Income (USD) · TTM
-80M-60M-40M-20M017 Q217 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q3
SNNAQ Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
19 Q3-47.91M
19 Q2-60.73M
19 Q1-72.71M
18 Q4-73.43M
18 Q3-65.33M
18 Q2-64.92M
18 Q1-57.54M
17 Q4-50.55M
17 Q3-47.64M
17 Q2-35.36M
Operating Income (USD) · TTM
-80M-60M-40M-20M017 Q217 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q3
SNNAQ Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
19 Q3-49.37M
19 Q2-59.92M
19 Q1-73.86M
18 Q4-76.5M
18 Q3-70.72M
18 Q2-68.46M
18 Q1-58.05M
17 Q4-48.57M
17 Q3-41.98M
17 Q2-31.98M
EBITDA (USD) · TTM
-80M-60M-40M-20M017 Q217 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q3
SNNAQ EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
19 Q3-52.02M
19 Q2-60.46M
19 Q1-74.4M
18 Q4-77.04M
18 Q3-71.58M
18 Q2-68.63M
18 Q1-58.24M
17 Q4-48.77M
17 Q3-42.2M
17 Q2-32M
Cash Flows (USD) · TTM
-80M-60M-40M-20M017 Q217 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q3
SNNAQ Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
19 Q3-54.64M
19 Q2-52.7M
19 Q1-60.05M
18 Q4-61.73M
18 Q3-60.31M
18 Q2-53.9M
18 Q1-49.76M
17 Q4-41.36M
17 Q3-32.22M
17 Q2-28.4M
EPS (USD) · TTM
-20-15-10-5017 Q217 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q3
SNNAQ EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
19 Q3-2
19 Q2-2.69
19 Q1-3.42
18 Q4-3.6
18 Q3-3.23
18 Q2-3.53
18 Q1-9.03
17 Q4-13.29
17 Q3-16.92
17 Q2-17.88
Expenses (USD) · TTM
020M40M60M80MR&DSG&ACapex17 Q217 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q3
SNNAQ Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
19 Q352.19M
19 Q259.95M
19 Q173.9M
18 Q476.54M
18 Q370.86M
18 Q268.67M
18 Q158.28M
17 Q448.84M
17 Q342.24M
17 Q232.23M
Shares Outstanding (USD) · TTM
-6M-4M-2M02MBuybacks (Repurchases)Stock-Based Compensation17 Q217 Q317 Q418 Q118 Q218 Q318 Q419 Q119 Q219 Q3
SNNAQ Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
19 Q3-5.12M
19 Q2-5.21M
19 Q1-5.33M
18 Q4-4.68M
18 Q3-4.43M
18 Q2-3.68M
18 Q1-2.86M
17 Q4-2.11M
17 Q3-1.19M
17 Q2-519K
Free Cash Flow Yield
-200000000%-150000000%-100000000%-50000000%0%med -1778266.02%Jan 25May 25Sep 25Jan 26May 26Sep 26
SNNAQ Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1778266.02%
Sep 26-177826596.37%
Aug 26-1778266.02%
Aug 26-1778266.02%
Aug 26-1778266.02%
Aug 26-1778266.02%
Jul 26-1778266.02%
Jul 26-1778266.02%
Jul 26-1778266.02%
Jul 26-1778266.02%
Jul 26-1778266.02%
Jun 26-1778266.02%
Jun 26-1778266.02%
Jun 26-1778266.02%
Jun 26-1778266.02%
May 26-1778266.02%
May 26-1778266.02%
May 26-1778266.02%
May 26-1778266.02%
May 26-1778266.02%
Apr 26-1778266.02%
Apr 26-1778266.02%
Apr 26-1778266.02%
Apr 26-1778266.02%
Mar 26-1778266.02%
Mar 26-1778266.02%
Mar 26-1778266.02%
Mar 26-1778266.02%
Feb 26-1778266.02%
Feb 26-1778266.02%
Feb 26-1778266.02%
Feb 26-1778266.02%
Jan 26-1778266.02%
Jan 26-1778266.02%
Jan 26-1778266.02%
Jan 26-1778266.02%
Jan 26-177826596.37%
Dec 25-1778266.02%
Dec 25-1778266.02%
Dec 25-1778266.02%
Dec 25-1778266.02%
Nov 25-1778266.02%
Nov 25-1778266.02%
Nov 25-1778266.02%
Nov 25-1778266.02%
Oct 25-1778266.02%
Oct 25-1778266.02%
Oct 25-1778266.02%
Oct 25-1778265.96%
Oct 25-1778266.02%
Sep 25-1778266.02%
Sep 25-1778266.02%
Sep 25-1778266.02%
Sep 25-1778266.02%
Aug 25-1778266.02%
Aug 25-1778266.02%
Aug 25-1778266.02%
Aug 25-1778266.02%
Aug 25-1778266.02%
Jul 25-1778266.02%
Jul 25-1778266.02%
Jul 25-1778266.02%
Jul 25-1778266.02%
Jun 25-1778266.02%
Jun 25-1778266.02%
Jun 25-1778265.96%
Jun 25-1778266.02%
May 25-1778266.02%
May 25-1778266.02%
May 25-1778266.02%
May 25-1778266.02%
May 25-1778266.02%
Apr 25-1778266.02%
Apr 25-1778266.02%
Apr 25-1778266.02%
Apr 25-1778266.02%
Mar 25-1778266.02%
Mar 25-1778266.02%
Mar 25-1778266.02%
Mar 25-1778266.02%
Feb 25-1778266.02%
Feb 25-1778266.02%
Feb 25-1778266.02%
Feb 25-1778266.02%
Jan 25-177826596.37%
Jan 25-1778266.02%
Jan 25-1778266.02%
Jan 25-1778266.02%
Jan 25-1778266.02%
Dec 24-1778266.02%
Dec 24-1778266.02%
Dec 24-1778266.02%
Dec 24-1778266.02%
Nov 24-1778266.02%
Nov 24-1778266.02%
Nov 24-1778266.02%
Nov 24-1778266.02%
Nov 24-1778266.02%
Oct 24-1778266.02%
Oct 24-1778266.02%
Price to Book
0000med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SNNAQ Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240
Sienna Biopharmaceuticals, Inc.
SNNAQ
Stockpicker

Video analysis: SNNAQ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.